Foresite Capital Management I as of June 30, 2021
Portfolio Holdings for Foresite Capital Management I
Foresite Capital Management I holds 4 positions in its portfolio as reported in the June 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| 10X Genomics Class A Common (TXG) | 88.5 | $147M | 750k | 195.82 | |
| Novavax (NVAX) | 8.6 | $14M | 67k | 212.30 | |
| Epizyme | 1.5 | $2.4M | 294k | 8.31 | |
| Acceleron Pharma | 1.4 | $2.4M | 19k | 125.50 |
